Omeros | OMER - Ebitda





Ebitda Veränderung Datum
Adma Biologics USD 73.59M 14.85M 2025-12
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Cytokinetics USD -169.32M 19.48M 2026-03
Gilead Sciences USD 3.02B 1.01B 2025-12
Heron Therapeutics USD -3.88M 5.63M 2024-09
Immunic USD -22.78M 753K 2024-06
Insmed USD -148.3M 165.88M 2026-03
Knight Therapeutics CAD 24.45M 3.46M 2025-12
MacroGenics USD 21.95M 55.39M 2025-09
Omeros USD -47.96M 7.39M 2023-09
Pacira USD 40.24M 1.53M 2026-03
Pfizer USD 5.99B 5.23B 2026-03
Sarepta Therapeutics USD -252.2M 84.16M 2025-12
United Therapeutics USD 379.5M 83.4M 2025-12
Vertex Pharmaceuticals USD 1.19B 195.3M 2026-03
Xoma USD 2.52M 7.98M 2024-06